Sana Biotechnology, Inc. (SANA)
3.26
-0.03
(-0.91%)
USD |
NASDAQ |
Apr 27, 16:00
3.27
+0.01
(+0.31%)
After-Hours: 19:24
Sana Biotechnology EPS Diluted (Quarterly) : -0.2132 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| ImmunityBio, Inc. | -0.0626 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Sarepta Therapeutics, Inc. | -3.934 |
| Beam Therapeutics, Inc. | 2.328 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -58.82M |
| Total Expenses (Quarterly) | 58.82M |
| Enterprise Value | 814.28M |
| Earnings Yield | -29.95% |
| Normalized Earnings Yield | -24.69 |